NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

A Study to Understand How the Study Medicine (PF-07976016) is Processed and Eliminated in Healthy Men

CompletedPhase 1

Sponsor: Pfizer

Conditions: Healthy Male Volunteers

Interventions: [14C] PF-07976016, PF-07976016, [14C] PF-07976016

Countries: Netherlands

The purpose of this study is to learn about how much the study medicine PF-07976016 will be taken up and processed by healthy male participants. The total number of weeks of the study is up to approximately 12 weeks.

Eligibility overview

Sex: MALE

Age: 18 Years to 65 Years

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Males, 18 to 65 years of age
* BMI 17.5 to 32 kg/m2 and a total body weight \>50 kg (110 lb)
* Willing and able to comply with all study procedures

Exclusion Criteria:

* History of irregular bowel movements or lactose intolerance
* Any medical or psychiatric condition or laboratory abnormality or other condition that may increase the risk of study participation
* Use of any prohibited or concomitant medication(s)
* Presence of specified abnormalities on diagnostic assessments including clinical laboratory tests
* Positive urine drug test
* History of alcohol abuse or repeated binge drinking and/or any other illicit drug use or dependence
* Use of tobacco/nicotine containing products in excess of the equivalent of 5 cigarettes/day
* Previous administration of an investigational product within 30 days preceding the first dose of study medicine in this study.

Locations (1)

Groningen, Netherlands